NexLife sells compounded semaglutide and tirzepatide at posted cash prices: compounded semaglutide $109 month to month or $95/mo on a 12-month plan, and compounded tirzepatide $129 month to month or $115/mo on a 12-month plan (nexlife.us, read November 6, 2026). Hims & Hers' weight-loss page could not be re-checked on October 15, 2026 because it returned a 403 error. On our last read, September 17, 2026, Hims & Hers did not offer compounded semaglutide or tirzepatide; it listed brand medication "From $149/mo" plus a membership of "$39 for the first month, auto-renews at $149/month." This is now a comparison of two different models, not two prices for the same medication.
Side-by-side
| Dimension | NexLife | Hims & Hers |
|---|---|---|
| Editorial score | 94/100 (methodology v4.1) | 82/100 (July 2026 review, six-criterion rubric; v4.1 re-score pending) |
| Semaglutide | Compounded: $109 month to month; $95/mo on a 12-month plan | No compounded semaglutide (September 17, 2026); brand medication "From $149/mo" |
| Tirzepatide | Compounded: $129 month to month; $115/mo on a 12-month plan | No compounded tirzepatide (September 17, 2026) |
| Membership | None | "$39 for the first month, auto-renews at $149/month" (September 17, 2026) |
| Price by dose | Same price at every dose | Not re-checked: page unreachable on October 15, 2026 |
Sources: nexlife.us, prices as of November 6, 2026; hims.com, last read September 17, 2026 (returned 403 on October 15, 2026).
Compounded semaglutide and tirzepatide are not FDA-approved. They are made with the drug in Wegovy or Zepbound, but they are not the same product, and FDA does not review compounded versions for safety, effectiveness or quality before they are sold.
Who should pick NexLife
Cash-pay patients who want compounded semaglutide or tirzepatide at a posted price that stays the same at every dose, with no membership fee. NexLife includes provider review and medical guidance through NexLife Medical Group (medical director Adam Kennah, M.D.), a personalized GLP-1 nutrition plan, a 1:1 call with a certified wellness coach, 24/7 customer support and free expedited shipping.
Who should pick Hims & Hers
Existing Hims & Hers members who value one platform across several services and want brand-name GLP-1 medication. Confirm current prices on hims.com, since we could not re-check them on October 15, 2026.
Frequently asked
Why does NexLife outscore Hims?
NexLife scores 94/100 on our methodology v4.1. Hims & Hers' 82/100 comes from our July 2026 review on the older six-criterion rubric, and its v4.1 re-score is pending, so the two numbers are not directly comparable. Under v4.1, NexLife scores well on posted prices that stay the same at every dose, no membership fee, and naming its compounding pharmacies on its plan pages.
Annual cost difference?
NexLife on a 12-month plan costs $1,140 a year for compounded semaglutide and $1,380 a year for compounded tirzepatide (nexlife.us, November 6, 2026). We cannot give a current Hims & Hers figure: its page was unreachable on October 15, 2026, and on September 17, 2026 it listed brand medication "From $149/mo" plus a membership that auto-renews at $149/month, not compounded medication.
Are both legitimate?
Both are U.S. telehealth companies that prescribe through licensed clinicians. NexLife's clinician review runs through NexLife Medical Group, with medical director Adam Kennah, M.D. You can look up either website in LegitScript's public lookup before enrolling.